Overexpression of the gene encoding cPLA2α (PLA2G4A) has been reported in patient samples from different solid cancers such as breast cancer [10], hepatocellular carcinoma [11], cervical cancer [12], prostate cancer [13], and lung cancer [14], as well as hematological cancers such as acute myeloid leukemia (AML) [15,16] and B-cell lymphocytic leukemia (B-CLL) [17]. The gene discussed is PLA2G4A; the disease is lung carcinoma.